Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection

References

• McCullin M, Fick RBJ. Pathogenesis of Pseudomonal lung disease in cystic fibrosis. Boca Raton, Fla: CRC Press, 1993.
   Google Scholar
• Parsons YN, Panagea S, Smart CH, Walshaw MJ, Hart CA, Winstanley C. Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. J Clin Microbiol 2002; 40:4607 - 11; http://dx.doi.org/10.1128/JCM.40.12.4607-4611.2002; PMID: 12454160
   PubMed Web of Science ®Google Scholar
• Levitan IB. The basic defect in cystic fibrosis. Science 1989; 244:1423; http://dx.doi.org/10.1126/science.2544028; PMID: 2544028
   PubMed Web of Science ®Google Scholar
• Speert DP. Prevention of severe lower respiratory infections in patients with cystic fibrosis. Semin Respir Infect 1989; 4:266 - 71; PMID: 2516638
   PubMedGoogle Scholar
• Piedra P, Ogra PL. Immunologic aspects of surface infections in the lung. J Pediatr 1986; 108:817 - 23; http://dx.doi.org/10.1016/S0022-3476(86)80751-X; PMID: 3084749
   PubMed Web of Science ®Google Scholar
• Welsh MJ, Smith AE. Cystic fibrosis. Sci Am 1995; 273:52 - 9; http://dx.doi.org/10.1038/scientificamerican1295-52; PMID: 8525348
   PubMed Web of Science ®Google Scholar
• Buret A, Cripps AW. The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis. Am Rev Respir Dis 1993; 148:793 - 805; http://dx.doi.org/10.1164/ajrccm/148.3.793; PMID: 8368651
   PubMed Web of Science ®Google Scholar
• Wood RE, Boat TF, Doershuk CF. Cystic fibrosis. Am Rev Respir Dis 1976; 113:833 - 78; PMID: 779549
   PubMed Web of Science ®Google Scholar
• Cripps AW, Dunkley ML, Taylor DC, Cousins S, Clancy RL. Immunity to Pseudomonas aeruginosa induced by OprF following intestinal immunization. Adv Exp Med Biol 1995; 371B:761 - 3; PMID: 7502893
   PubMedGoogle Scholar
• Thomas LD, Kyd JM, Bastin DA, Dunkley ML, Cripps AW. Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa. FEMS Immunol Med Microbiol 2003; 37:155 - 60; http://dx.doi.org/10.1016/S0928-8244(03)00073-7; PMID: 12832119
   PubMed Web of Science ®Google Scholar
• Thomas LD, Cripps AW, Kyd JM. Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection. Vaccine 2009; 27:3324 - 30; http://dx.doi.org/10.1016/j.vaccine.2009.01.085; PMID: 19200832
   PubMed Web of Science ®Google Scholar
• Thomas LD, Dunkley ML, Moore R, Reynolds S, Bastin DA, Kyd JM, et al. Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung. Vaccine 2000; 19:348 - 57; http://dx.doi.org/10.1016/S0264-410X(00)00146-8; PMID: 10930690
   PubMed Web of Science ®Google Scholar
• Cripps AW, Dunkley ML, Clancy RL. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Infect Immun 1994; 62:1427 - 36; PMID: 8132349
   PubMed Web of Science ®Google Scholar
• Cripps AW, Peek K, Dunkley M, Vento K, Marjason JK, McIntyre ME, et al. Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects. Infect Immun 2006; 74:968 - 74; http://dx.doi.org/10.1128/IAI.74.2.968-974.2006; PMID: 16428742
   PubMed Web of Science ®Google Scholar
• Döring G, Pier GB. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine 2008; 26:1011 - 24; http://dx.doi.org/10.1016/j.vaccine.2007.12.007; PMID: 18242792
   PubMed Web of Science ®Google Scholar
• Bumann D, Behre C, Behre K, Herz S, Gewecke B, Gessner JE, et al. Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers. Vaccine 2010; 28:707 - 13; http://dx.doi.org/10.1016/j.vaccine.2009.10.080; PMID: 19887136
   PubMed Web of Science ®Google Scholar
• Sharma A, Krause A, Worgall S. Recent developments for Pseudomonas vaccines. Hum Vaccin 2011; 7:999 - 1011; http://dx.doi.org/10.4161/hv.7.10.16369; PMID: 21941090
   PubMed Web of Science ®Google Scholar
• Sorichter S, Baumann U, Baumgart A, Walterspacher S, von Specht BU. Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease. Vaccine 2009; 27:2755 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.03.010; PMID: 19366571
   PubMed Web of Science ®Google Scholar
• Döring G. Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients. Int J Med Microbiol 2010; 300:573 - 7; http://dx.doi.org/10.1016/j.ijmm.2010.08.010; PMID: 20940108
   PubMed Web of Science ®Google Scholar
• Döring G. Vaccine development for patients with cystic fibrosis. Expert Rev Vaccines 2012; 11:259 - 61; http://dx.doi.org/10.1586/erv.12.1; PMID: 22380816
   PubMed Web of Science ®Google Scholar
• Beckmann C, Brittnacher M, Ernst R, Mayer-Hamblett N, Miller SI, Burns JL. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect Immun 2005; 73:444 - 52; http://dx.doi.org/10.1128/IAI.73.1.444-452.2005; PMID: 15618183
   PubMed Web of Science ®Google Scholar
• Rao AR, Splaingard MS, Gershan WM, Havens PL, Thill A, Barbieri JT. Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies. Pediatr Pulmonol 2005; 39:402 - 7; http://dx.doi.org/10.1002/ppul.20194; PMID: 15666370
   PubMed Web of Science ®Google Scholar
• Jaffar-Bandjee MC, Carrère J, Bally M, Guy-Crotte O, Galabert C. Immunoenzymometric assays for alkaline protease and exotoxin A from Pseudomonas aeruginosa: development and use in detecting exoproteins in clinical isolates from patients with cystic fibrosis. Eur J Clin Chem Clin Biochem 1994; 32:893 - 9; PMID: 7696436
   PubMedGoogle Scholar
• Pedersen SS, Møller H, Espersen F, Sørensen CH, Jensen T, Høiby N. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis. APMIS 1992; 100:326 - 34; http://dx.doi.org/10.1111/j.1699-0463.1992.tb00879.x; PMID: 1581041
   PubMed Web of Science ®Google Scholar
• Pressler T, Pedersen SS, Espersen F, Høiby N, Koch C. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA. Clin Exp Immunol 1990; 81:428 - 34; http://dx.doi.org/10.1111/j.1365-2249.1990.tb05351.x; PMID: 2118845
   PubMed Web of Science ®Google Scholar
• Fomsgaard A, Dinesen B, Shand GH, Pressler T, Høiby N. Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. J Clin Microbiol 1989; 27:1222 - 9; PMID: 2502558
   PubMed Web of Science ®Google Scholar
• Baltimore RS, Fick RB Jr., Fino L. Antibody to multiple mucoid strains of Pseudomonas aeruginosa in patients with cystic fibrosis, measured by an enzyme-linked immunosorbent assay. Pediatr Res 1986; 20:1085 - 90; http://dx.doi.org/10.1203/00006450-198611000-00005; PMID: 3099248
   PubMed Web of Science ®Google Scholar
• Shand GH, Pedersen SS, Brown MR, Høiby N. Serum antibodies to Pseudomonas aeruginosa outer-membrane proteins and iron-regulated membrane proteins at different stages of chronic cystic fibrosis lung infection. J Med Microbiol 1991; 34:203 - 12; http://dx.doi.org/10.1099/00222615-34-4-203; PMID: 1902261
   PubMed Web of Science ®Google Scholar
• Likavcanova E, Lagacé J. Quantitative analysis of immunoglobulin G subclass responses to Pseudomonas aeruginosa antigens in cystic fibrosis. J Med Microbiol 1992; 36:437 - 44; http://dx.doi.org/10.1099/00222615-36-6-437; PMID: 1613784
   PubMed Web of Science ®Google Scholar
• Kubesch P, von Specht BU, Tümmler B. Immune response in cystic fibrosis to outer membrane proteins of Pseudomonas aeruginosa. Zentralbl Bakteriol Mikrobiol Hyg A 1988; 269:395 - 410; http://dx.doi.org/10.1016/S0176-6724(88)80183-4; PMID: 3146171
   PubMedGoogle Scholar
• Kappler M, Kraxner A, Reinhardt D, Ganster B, Griese M, Lang T. Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis. Thorax 2006; 61:684 - 8; http://dx.doi.org/10.1136/thx.2005.049536; PMID: 16449259
   PubMed Web of Science ®Google Scholar
• Fito-Boncompte L, Chapalain A, Bouffartigues E, Chaker H, Lesouhaitier O, Gicquel G, et al. Full virulence of Pseudomonas aeruginosa requires OprF. Infect Immun 2011; 79:1176 - 86; http://dx.doi.org/10.1128/IAI.00850-10; PMID: 21189321
   PubMed Web of Science ®Google Scholar
• Edrington TC, Kintz E, Goldberg JB, Tamm LK. Structural basis for the interaction of lipopolysaccharide with outer membrane protein H (OprH) from Pseudomonas aeruginosa. J Biol Chem 2011; 286:39211 - 23; http://dx.doi.org/10.1074/jbc.M111.280933; PMID: 21865172
   PubMed Web of Science ®Google Scholar
• McPhee JB, Tamber S, Bains M, Maier E, Gellatly S, Lo A, et al. The major outer membrane protein OprG of Pseudomonas aeruginosa contributes to cytotoxicity and forms an anaerobically regulated, cation-selective channel. FEMS Microbiol Lett 2009; 296:241 - 7; http://dx.doi.org/10.1111/j.1574-6968.2009.01651.x; PMID: 19486157
   PubMed Web of Science ®Google Scholar
• Wainwright CE, France MW, O’Rourke P, Anuj S, Kidd TJ, Nissen MD, et al. Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis. Thorax 2009; 64:926 - 31; http://dx.doi.org/10.1136/thx.2008.112466; PMID: 19574243
   PubMed Web of Science ®Google Scholar
• Griffiths AL, Jamsen K, Carlin JB, Grimwood K, Carzino R, Robinson PJ, et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med 2005; 171:1020 - 5; http://dx.doi.org/10.1164/rccm.200409-1194OC; PMID: 15709051
   PubMed Web of Science ®Google Scholar
• Kidd TJ, Ritchie SR, Ramsay KA, Grimwood K, Bell SC, Rainey PB. Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One 2012; 7:e44199; http://dx.doi.org/10.1371/journal.pone.0044199; PMID: 22970178
   PubMed Web of Science ®Google Scholar
• Kubesch P, Lingner M, Grothues D, Wehsling M, Tümmler B. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung. Scand J Gastroenterol Suppl 1988; 143:77 - 80; http://dx.doi.org/10.3109/00365528809090222; PMID: 3133755
   PubMedGoogle Scholar
• von Specht B, Knapp B, Hungerer K, Lücking C, Schmitt A, Domdey H. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates. J Biotechnol 1996; 44:145 - 53; http://dx.doi.org/10.1016/0168-1656(95)00161-1; PMID: 8717398
   PubMed Web of Science ®Google Scholar
• Pressler T, Kronborg G, Shand GH, Mansa B, Høiby N. Determination of IgG subclass antibodies to Pseudomonas aeruginosa outer membrane proteins in cystic fibrosis lung infection using immunoblotting and enzyme-linked immunosorbent assay. Med Microbiol Immunol 1992; 181:339 - 49; http://dx.doi.org/10.1007/BF00191546; PMID: 1287420
   PubMed Web of Science ®Google Scholar
• Brown SM, Howell ML, Vasil ML, Anderson AJ, Hassett DJ. Cloning and characterization of the katB gene of Pseudomonas aeruginosa encoding a hydrogen peroxide-inducible catalase: purification of KatB, cellular localization, and demonstration that it is essential for optimal resistance to hydrogen peroxide. J Bacteriol 1995; 177:6536 - 44; PMID: 7592431
   PubMed Web of Science ®Google Scholar
• Brett MM, Ghoneim AT, Littlewood JM, Losowsky MS. Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J Clin Pathol 1986; 39:1124 - 9; http://dx.doi.org/10.1136/jcp.39.10.1124; PMID: 3097080
   PubMed Web of Science ®Google Scholar
• Pedersen SS. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS Suppl 1992; 28:1 - 79; PMID: 1449848
   PubMedGoogle Scholar
• Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy. Clin Infect Dis 2012; 55:1188 - 97; http://dx.doi.org/10.1093/cid/cis624; PMID: 22806596
   PubMed Web of Science ®Google Scholar
• Hayes E, Pohl K, McElvaney NG, Reeves EP. The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch Immunol Ther Exp (Warsz) 2011; 59:97 - 112; http://dx.doi.org/10.1007/s00005-011-0113-6; PMID: 21311988
   PubMed Web of Science ®Google Scholar
• Ratner D, Mueller C. Immune responses in cystic fibrosis: are they intrinsically defective?. Am J Respir Cell Mol Biol 2012; 46:715 - 22; http://dx.doi.org/10.1165/rcmb.2011-0399RT; PMID: 22403802
   PubMed Web of Science ®Google Scholar
• Sedlak-Weinstein E, Cripps AW, Kyd JM, Foxwell AR. Pseudomonas aeruginosa: the potential to immunise against infection. Expert Opin Biol Ther 2005; 5:967 - 82; http://dx.doi.org/10.1517/14712598.5.7.967; PMID: 16018741
   PubMed Web of Science ®Google Scholar
• Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 138:699 - 704; http://dx.doi.org/10.1067/mpd.2001.112897; PMID: 11343046
   PubMed Web of Science ®Google Scholar
• Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 1995; 310:1571 - 2; http://dx.doi.org/10.1136/bmj.310.6994.1571; PMID: 7787647
   PubMed Web of Science ®Google Scholar
• Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996; 21:267 - 75; http://dx.doi.org/10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; PMID: 8726151
   PubMed Web of Science ®Google Scholar
• Kidd TJ, Ramsay KA, Hu H, Bye PTB, Elkins MR, Grimwood K, et al, ACPinCF Investigators. Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients. J Clin Microbiol 2009; 47:1503 - 9; http://dx.doi.org/10.1128/JCM.00014-09; PMID: 19261796
   PubMed Web of Science ®Google Scholar
• Murphy TF, Bartos LC. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect Immun 1989; 57:2938 - 41; PMID: 2476393
   PubMed Web of Science ®Google Scholar
• Suzuki H, Terada T. Removal of dodecyl sulfate from protein solution. Anal Biochem 1988; 172:259 - 63; http://dx.doi.org/10.1016/0003-2697(88)90440-X; PMID: 3189769
   PubMed Web of Science ®Google Scholar